All lobbying filings

GRANT PARK STRATEGIES

GRANT PARK STRATEGIES filed a Q4 report for GRAIL, INC. on January 20, 2026, reporting $30,000 in lobbying income.

Lobbying for GRAIL, INC. · Biotechnology company.

All filings by GRANT PARK STRATEGIES · Everything GRAIL, INC. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues related to oncology and early multi-cancer detection, including diagnostics and screening; The Multi-Cancer Early Detection Screening Coverage Act.

Medicare/Medicaid

Issues related to oncology and early multi-cancer detection, including diagnostics and screening; The Multi-Cancer Early Detection Screening Coverage Act.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.